We are live on
!
Find out more
KS
Karpas Strategies Portfolio holdings
AUM
$319M
1-Year Est. Return
14.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.63%
1 Year Est. Return
+14.42%
3 Year Est. Return
+16.12%
5 Year Est. Return
+59.2%
10 Year Est. Return
+120.19%
AUM
$264M
AUM Growth
+$8.96M
(+3.5%)
Cap. Flow
-$14.1M
Cap. Flow
% of AUM
-5.35%
Top 10 Holdings %
Top 10 Hldgs %
45.66%
Holding
129
New
5
Increased
14
Reduced
33
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$638K |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$367K |
| 3 |
Comcast
CMCSA
|
+$347K |
| 4 |
HCA Healthcare
HCA
|
+$335K |
| 5 |
Lockheed Martin
LMT
|
+$271K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$755K |
| 2 |
Honeywell
HON
|
+$466K |
| 3 |
Marriott International
MAR
|
+$410K |
| 4 |
NAB
NATL AUSTRALIA BK LTD ADS5
NAB
|
+$401K |
| 5 |
Wells Fargo
WFC
|
+$364K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 27.27% |
| 2 | Healthcare | 15.91% |
| 3 | Communication Services | 14.53% |
| 4 | Energy | 10.26% |
| 5 | Utilities | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Xylem
XYL
$25.1B
| $270K | 0.1% |
2,568
| – | – |
|
102
Ameriprise Financial
AMP
$49.4B
| $260K | 0.1% |
1,120
| – | – |
|
103
St. Joe Company
JOE
$3.66B
| $260K | 0.1% |
6,050
| – | – |
|
104
Boeing
BA
$166B
| $259K | 0.1% |
1,018
| – | – |
|
105
Manulife Financial
MFC
$72.7B
| $258K | 0.1% |
12,000
| – | – |
|
106
Hyatt Hotels
H
$15.1B
| $223K | 0.08% |
+2,700
| New | +$212K |
|
107
Fox Class A
FOXA
$28.4B
| $204K | 0.08% |
+5,653
| New | +$198K |
|
108
Suncor Energy
SU
$84.1B
| $201K | 0.08% |
+9,600
| New | +$188K |
|
109
Viatris
VTRS
$19.1B
| $181K | 0.07% |
12,984
-43
| -0.3% | -$701 |
|
110
Ecolab
ECL
$77B
| – | – |
-925
| Closed | -$200K |
|
|
WPX
111
DELISTED
WPX Energy, Inc.
WPX
| – | – |
-17,500
| Closed | -$143K |
|
|
NAB
112
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
| – | – |
-46,000
| Closed | -$401K |
|
|
HCA
113
DELISTED
HCA INC
HCA
| – | – |
-1,900
| Closed | -$312K |
|
Similar funds
RMC
GH
GFWEX
CCMLC
CU
LWMG
THWM
VFPI
Karpas Strategies's Q1 2021 Portfolio in Review
As of Q1 2021, Karpas Strategies held 129 positions worth $264M, up 3.5% from $255M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Karpas Strategies withdrew a net $14.1M in Q1 2021, closing 20 positions and reducing 33 holdings. Its most notable exit was NATL AUSTRALIA BK LTD ADS5, an estimated $401K position sold in full.
By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Karpas Strategies opened a new position in HCA Healthcare worth $358K.
- Karpas Strategies's largest Q1 2021 buy was HCA Healthcare: 1,900 shares worth $358K.
- Karpas Strategies added most to Pfizer in Q1 2021, an estimated $638K increase.
- Karpas Strategies's biggest Q1 2021 reduction was Charles Schwab, cutting an estimated $755K.
- Karpas Strategies fully exited NATL AUSTRALIA BK LTD ADS5 in Q1 2021, selling an estimated $401K.
- Karpas Strategies's ten largest holdings make up 46% of its $264M portfolio in Q1 2021.
- Karpas Strategies opened 5 new positions and closed 20 in Q1 2021.
- Karpas Strategies's portfolio value rose 3.5% quarter-over-quarter to $264M.
Based on Karpas Strategies's 13F filing for Q1 2021, filed 5 May 2021.